Key Financial Data Of Reporting Company

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7608023

Concept 2021-04-01 to
2021-12-31
As at
2021-12-31
2021-10-01 to
2021-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
44,179,000,000 JPY
Ordinary profit (loss)
4,790,000,000 JPY
Net assets
48,412,000,000 JPY
Total assets
87,536,000,000 JPY
Basic earnings (loss) per share
143.76
242.10
Diluted earnings per share
Equity-to-asset ratio
0.553 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.